Related Experiment Video
Updated: Jun 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis
Heather L Armata1, Diane Golebiowski, Dae Young Jung
1Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Abstract:
Ataxia telangiectasia (A-T) patients can develop multiple clinical pathologies, including neuronal degeneration, an elevated risk of cancer, telangiectasias, and growth retardation. Patients with A-T can also exhibit an increased risk of insulin resistance and type 2 diabetes. The ATM protein kinase, the product of the gene mutated in A-T patients (Atm), has been implicated in metabolic disease, which is characterized by insulin resistance and increased cholesterol and lipid levels, blood pressure, and atherosclerosis. ATM phosphorylates the p53 tumor suppressor on a site (Ser15) that regulates transcription activity. To test whether the ATM pathway that regulates insulin resistance is mediated by p53 phosphorylation, we examined insulin sensitivity in mice with a germ line mutation that replaces the p53 phosphorylation site with alanine. The loss of p53 Ser18 (murine Ser15) led to increased metabolic stress, including severe defects in glucose homeostasis. The mice developed glucose intolerance and insulin resistance. The insulin resistance correlated with the loss of antioxidant gene expression and decreased insulin signaling. N-Acetyl cysteine (NAC) treatment restored insulin signaling in late-passage primary fibroblasts. The addition of an antioxidant in the diet rendered the p53 Ser18-deficient mice glucose tolerant. This analysis demonstrates that p53 phosphorylation on an ATM site is an important mechanism in the physiological regulation of glucose homeostasis.
Insights
Ataxia telangiectasia (A-T) is linked to metabolic issues. P53 phosphorylation by ATM is crucial for regulating glucose homeostasis and preventing insulin resistance.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disease
Background:
- Ataxia telangiectasia (A-T) is a genetic disorder causing neurodegeneration, cancer predisposition, and metabolic dysfunction.
- ATM protein kinase, mutated in A-T, plays a role in metabolic diseases characterized by insulin resistance and dyslipidemia.
- ATM regulates p53 tumor suppressor activity via phosphorylation at Ser15, a site critical for its transcriptional function.
Purpose of the Study:
- To investigate if the ATM pathway regulating insulin resistance involves p53 phosphorylation.
- To determine the role of p53 phosphorylation at Ser15 in glucose homeostasis and insulin sensitivity.
Main Methods:
- Examined insulin sensitivity in mice with a germline mutation replacing the p53 phosphorylation site (Ser18 in mice, Ser15 in humans) with alanine.
- Assessed glucose homeostasis, insulin resistance, and insulin signaling pathways.
- Utilized N-Acetyl cysteine (NAC) treatment and dietary antioxidant supplementation.
Main Results:
- Mice lacking p53 phosphorylation at Ser18 exhibited severe glucose homeostasis defects, including glucose intolerance and insulin resistance.
- Insulin resistance correlated with reduced antioxidant gene expression and impaired insulin signaling.
- NAC treatment restored insulin signaling in fibroblasts, and dietary antioxidants improved glucose tolerance in deficient mice.
Conclusions:
- p53 phosphorylation on an ATM site is a key mechanism in the physiological regulation of glucose homeostasis.
- This pathway is critical for maintaining metabolic health and preventing insulin resistance.
- Targeting this pathway may offer therapeutic strategies for metabolic disorders.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
